Elevated Salivary Antioxidant Biomarkers are Favorable for Clinical Pregnancy in Women Undergoing IVF: A Prospective Cohort Study

唾液抗氧化生物标志物升高有利于接受体外受精治疗的女性临床妊娠:一项前瞻性队列研究

阅读:1

Abstract

BACKGROUND AND AIMS: The imbalance of oxidants and antioxidants mediates cell damage through a phenomenon known as oxidative stress. The increase in fertility problems led to a growing focus on factors that affect the outcome of reproductive- assisted treatments. This study aimed to investigate the levels of oxidant-antioxidants in serum and saliva, as systemic sources of oxidative stress, in relation to the outcome of in vitro fertilization (IVF) treatment. METHODS: This study was conducted on 80 women who were candidates for frozen embryo transfer. Serum and saliva samples were collected from these individuals according to standardized protocols before embryo transfer. The levels of MDA, SOD, TOC, and TAC in serum and saliva were measured using ELISA kits, and the relationship between these biomarkers and IVF outcomes was evaluated using t-tests. RESULTS: The serum and salivary SOD and TAC were significantly higher (p = 0.012, p = 0.022, p = 0.037, p = 0.020, respectively), the serum and saliva MDA, TOS, and OSI were significantly lower (p = 0.031, p = 0.012, p = 0.019, p = 0.036, respectively) in women with positive beta hCG (β-hCG) compared to those with negative β-hCG. The independent predictor's role of salivary TAC, and TOS and serum SOD, TOS, and OSI was comfirmed by a logistic regression model. Based on ROC analysis, serum and salivary TOS had the highest predictive value (AUC = 0.65). CONCLUSION: The women with positive β-hCG had elevated levels of antioxidants and decreased levels of oxidant biomarkers in both serum and saliva. Further research is needed to confirm saliva as a readily available medium for predicting IVF treatment outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。